PREVENA System Could Help Reduce Complications, Studies Suggest

KCI announces that recently published data stemming from two studies demonstrate that closed incision negative pressure therapy (ciNPT) with the PREVENA Incision Management System reduced postsurgical wound complication potential in patients recovering from oncological breast surgery and breast reconstruction, respectively.

One study titled, “The Impact of Closed Incision Negative Pressure Therapy on Postoperative Breast Reconstruction Outcomes,” showed that patients who received ciNPT with the PREVENA System had significantly lower rates of overall complications and returns to the operating room compared to those in the standard of care (SOC) for incision management after breast reconstruction post-mastectomy group. In addition, patients in the PREVENA Therapy group overall had a shorter mean time to complete removal of all drains than the SOC group, averaging 9.9 days versus 13.1, respectively.

In a separate study titled, “Closed Incision Negative Pressure Therapy in Oncological Breast Surgery: Comparison with Standard Care Dressings,” researchers found that patients in the PREVENA Therapy group showed significantly lower postsurgical complication rates, demonstrating 4 percent in the PREVENA Therapy group versus 45 percent in the SOC group.

“Minimizing the risk of complications for the patients in my care is of the utmost importance to me as a practicing plastic surgeon, and this recent data adds to the established body of evidence that demonstrates the ability of PREVENA Therapy to help preserve outcomes for breast reconstruction patients,” said Ron Silverman, MD, FACS, Chief Medical Officer, KCI, an Acelity Company. “Further, this data has implications for lowering healthcare costs and improving quality and the patient experience as post-operative complications create a tremendous burden impacting patients, surgeons and payers. At KCI, we are dedicated to bringing to market innovations that address these needs supported by proven-real world results that improve patients’ lives.”

Study Overviews

“The Impact of Closed Incision Negative Pressure Therapy on Postoperative Breast Reconstruction Outcomes”:

  • A single site, retrospective review of records for 356 adult female patients who underwent breast reconstruction post-mastectomy was conducted. Records were divided into two groups for comparative analysis: patients who received SOC versus patients who received ciNPT with the PREVENA Incision Management System for closed incision management post breast reconstruction.

“Closed Incision Negative Pressure Therapy in Oncological Breast Surgery: Comparison with Standard Care Dressings”:

  • In a study of 37 patients undergoing oncological breast surgery, 17 patients (25 surgeries) received ciNPT with the PREVENA Incision Management System and the remaining 20 patients (20 surgeries) had SOC.

Both studies were published in Plastic and Reconstructive Surgery – Global Open.

[Source(s): Acelity, Business Wire]